Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Muhammet Ferhat CELİK, Istanbul University
ClinicalTrials.gov Identifier:
NCT01613391
First received: June 5, 2012
Last updated: June 8, 2012
Last verified: June 2012
  Purpose

This study aimed to measure, compare apelin, resistin, visfatin levels in patients underwent to RYGBP, LAGB and their relation with obesity.


Condition
Morbid Obesity

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Effect of Roux-en-Y Gastric Bypass Versus Laparoscopic Adjustable Gastric Band Operations on Resistin, Apelin and Visfatin Peptides

Resource links provided by NLM:


Further study details as provided by Istanbul University:

Enrollment: 30
Study Start Date: July 2011
Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
RYGBP
Patients underwent Roux-en-Y Gastric Bypass for morbid obesity.
LAGB
Patients underwent Laparoscopic Adjustable Gastric Banding for morbid obesity.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Morbidly obese 15 patients underwent LAGB and 15 patients underwent RYGBP

Criteria

Inclusion Criteria:

  • Clinical diagnosis of morbid obesity
  • Being underwent LAGB or RYGBP

Exclusion Criteria:

  • Having prior abdominal surgery history
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01613391

Locations
Turkey
Istanbul University Cerrahpasa Medical Faculty
Istanbul, Turkey, 34098
Sponsors and Collaborators
Istanbul University
  More Information

No publications provided

Responsible Party: Muhammet Ferhat CELİK, Medical Doctor, Istanbul University
ClinicalTrials.gov Identifier: NCT01613391     History of Changes
Other Study ID Numbers: IU-BS-2012-RAV
Study First Received: June 5, 2012
Last Updated: June 8, 2012
Health Authority: Turkey: Ministry of Health

Keywords provided by Istanbul University:
Visfatin
Resistin
Apelin
roux-en-y gastric bypass
laparoscopic adjustable gastric banding
morbid obesity

Additional relevant MeSH terms:
Obesity
Obesity, Morbid
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on July 10, 2014